Skip to main content

Table 2 Cross-reactivity of probes used for in situ hybridization

From: MARK4 and MARK3 associate with early tau phosphorylation in Alzheimer’s disease granulovacuolar degeneration bodies

 

MARK1

MARK2

MARK3

MARK4

Length

580 bp

600 bp

590 bp

601 bp

MARK1

100%

38.7%

55.6%

50.4%

MARK2

51.9%

100%

36.1%

52.6%

MARK3

55.9%

39.3%

100%

52.2%

MARK4

48.1%

42.3%

46.6%

100%

  1. Percentages are overall sequence identity of probes toward each MARK family isoform.
Back to article page

Acta Neuropathologica Communications

ISSN: 2051-5960

Contact us